{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:57:53Z","timestamp":1795060673434,"version":"4.10.2"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec id=\"ab-eoi230064-4\"><jats:title>Importance<\/jats:title><jats:p>Preterm infants screened for retinopathy of prematurity (ROP) are at risk for heterogenous neurodevelopment outcomes that are difficult to predict.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-5\"><jats:title>Objective<\/jats:title><jats:p>To characterize the potential association between socioeconomic and clinical risk factors and neurodevelopmental outcomes in a diverse, multicenter cohort of premature neonates screened for ROP.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was a retrospective cohort study using electronic medical records and US Census Bureau income data. This study was performed at academic (University of California, Los Angeles [UCLA] Mattel Children\u2019s Hospital and UCLA Santa Monica Hospital), community (Cedars-Sinai Medical Center), and LA county (Harbor-UCLA Medical Center) neonatal intensive care units. Participants included infants who met American Academy of Pediatrics guidelines for ROP screening and had records from at least 1 Bayley Scales of Infant and Toddler Development (BSID) neurodevelopment assessment between 0 and 36 months of adjusted age. Data analyses were conducted from January 1, 2011, to September 1, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-7\"><jats:title>Exposures<\/jats:title><jats:p>Demographic and clinical information, proxy household income, and health insurance type were collected as risk factors.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Neurodevelopmental outcomes in the cognitive, language, and motor domains measured via BSID were the primary outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-9\"><jats:title>Results<\/jats:title><jats:p>A total of 706 infants (mean [SD] age, 28.6 [2.4] weeks; 375 male [53.1%]) met inclusion criteria. In a multivariable model, which included adjustments for birth weight, sex, insurance type, intraventricular hemorrhage (IVH), and age at assessment, public health insurance was associated with a 4-fold\u2009increased risk of moderate to severe neurodevelopmental impairment (NDI) in cognitive and language domains (cognitive, odds ratio [OR], 3.65; 95% CI, 2.28-5.86; <jats:italic>P<\/jats:italic>\u2009=\u20098.1 \u00d7 10<jats:sup>\u22128<\/jats:sup>; language, OR, 3.96; 95% CI, 2.61-6.02; <jats:italic>P<\/jats:italic>\u2009=\u20091.0 \u00d7 10<jats:sup>\u221210<\/jats:sup>) and a 3-fold\u2009increased risk in the motor domain (motor, OR, 2.60; 95% CI, 1.59-4.24; <jats:italic>P<\/jats:italic>\u2009= 1.4 \u00d7 10<jats:sup>\u22124<\/jats:sup>). In this adjusted model, clinical factors that were associated with an increased risk of moderate to severe NDI included lower birth weight, diagnosis of IVH, male sex, and older age at time of Bayley assessment. In unadjusted analyses, infants who received either laser or anti-VEGF treatment, compared with infants without treatment-requiring ROP, had lower BSID scores in multiple domains at 0 to 12 months, 12 to 24 months, and 24 to 36 months (DATA). In the multivariable model, treatment type was no longer associated with worse neurodevelopmental outcomes in any domain.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi230064-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Study results suggest an association between public insurance type and NDI in a diverse population screened for ROP, indicating the complexities of neurodevelopment. This study also supports the early neurodevelopmental safety of anti-VEGF treatment, as anti-VEGF therapy was not found to be independently associated with worse NDI in any domain.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2023.4787","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T15:32:47Z","timestamp":1698334367000},"page":"1125","source":"Crossref","is-referenced-by-count":16,"title":["Neurodevelopmental Outcomes in Infants Screened for Retinopathy of Prematurity"],"prefix":"10.1001","volume":"141","author":[{"given":"Reem","family":"Karmouta","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Strawbridge","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Langston","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Altendahl","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Developmental Biology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Khitri","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Chu","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Developmental Biology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Tsui","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7479","key":"eoi230064r1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/bmj.329.7479.1390","article-title":"Neurodevelopmental outcomes after preterm birth.","volume":"329","author":"Colvin","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"eoi230064r2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1542\/peds.2013-0372","article-title":"Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants.","volume":"133","author":"Bolisetty","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"eoi230064r3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/jcm10040861","article-title":"Early diagnostics and early intervention in neurodevelopmental disorders-age-dependent challenges and opportunities.","volume":"10","author":"Hadders-Algra","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"eoi230064r4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamapediatrics.2015.2175","article-title":"Prognostic factors for poor cognitive development in children born very preterm or with very low birth weight: a systematic review.","volume":"169","author":"Linsell","year":"2015","journal-title":"JAMA Pediatr"},{"key":"eoi230064r5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.816409","article-title":"Severe retinopathy of prematurity associated with neurodevelopmental disorder in children.","volume":"10","author":"Choi","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"eoi230064r6","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1038\/s41598-022-09053-8","article-title":"Neurodevelopmental outcomes in very low birthweight infants with retinopathy of prematurity in a nationwide cohort study.","volume":"12","author":"Ahn","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"eoi230064r7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.siny.2015.06.004","article-title":"Retinopathy of prematurity and neurodevelopmental disabilities in premature infants.","volume":"20","author":"Beligere","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"eoi230064r8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000487847","article-title":"Relation of retinopathy of prematurity to brain volumes at term equivalent age and developmental outcome at 2 years of corrected age in very preterm infants.","volume":"114","author":"Sveinsd\u00f3ttir","year":"2018","journal-title":"Neonatology"},{"key":"eoi230064r9","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.679546","article-title":"Severe retinopathy of prematurity is not independently associated with worse neurodevelopmental outcomes in preterm neonates.","volume":"9","author":"Altendahl","year":"2021","journal-title":"Front Pediatr"},{"issue":"6","key":"eoi230064r10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity.","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"eoi230064r12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0734282906297199","article-title":"Test review: Bayley, N. (2006). Bayley Scales of Infant and Toddler Development, 3rd ed. San Antonio, TX: Harcourt Assessment.","volume":"25","author":"Albers","year":"2007","journal-title":"J Psychoeduc Assess"},{"issue":"5","key":"eoi230064r13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1001\/jamaophthalmol.2022.0667","article-title":"Association between social determinants of health and retinopathy of prematurity outcomes.","volume":"140","author":"Karmouta","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"eoi230064r14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12939-021-01436-z","article-title":"The convergence of racial and income disparities in health insurance coverage in the US.","volume":"20","author":"Lee","year":"2021","journal-title":"Int J Equity Health"},{"issue":"2","key":"eoi230064r15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3486","article-title":"The effect of lowering public insurance income limits on hospitalizations for low-income children.","volume":"142","author":"Bettenhausen","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"eoi230064r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262607","article-title":"Low household income and neurodevelopment from infancy through adolescence.","volume":"17","author":"Hair","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"eoi230064r17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2022.14791","article-title":"The US Medicaid program: coverage, financing, reforms, and implications for health equity.","volume":"328","author":"Donohue","year":"2022","journal-title":"JAMA"},{"key":"eoi230064r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101782","article-title":"Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches.","volume":"56","author":"Juul","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"1","key":"eoi230064r19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41398-022-01779-3","article-title":"Socioeconomic status, BMI, and brain development in children.","volume":"12","author":"Dennis","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"11","key":"eoi230064r20","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41380-021-01130-0","article-title":"Associations of family income with cognition and brain structure in USA children: prevention implications.","volume":"26","author":"Tomasi","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"4","key":"eoi230064r21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity.","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"eoi230064r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230678","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity.","volume":"15","author":"Arima","year":"2020","journal-title":"PLoS One"},{"key":"eoi230064r23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajo.2021.06.034","article-title":"Cognitive outcomes following intravitreal bevacizumab for retinopathy of prematurity: 4- to 6-year outcomes in a prospective cohort.","volume":"234","author":"Chou","year":"2022","journal-title":"Am J of Ophthalmol"},{"issue":"11","key":"eoi230064r24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1055\/s-0040-1710556","article-title":"Bevacizumab for retinopathy of prematurity: 2-year neurodevelopmental follow-up.","volume":"38","author":"Zayek","year":"2021","journal-title":"Am J Perinatol"},{"issue":"1","key":"eoi230064r25","doi-asserted-by":"publisher","first-page":"10.e1","DOI":"10.1016\/j.jaapos.2022.11.020","article-title":"Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.","volume":"27","author":"Wallace","year":"2023","journal-title":"J AAPOS"},{"key":"eoi230064r26","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.2147\/OPTH.S378520","article-title":"Postnatal growth trajectories and neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity.","volume":"16","author":"Zhang","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"eoi230064r27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3928\/23258160-20190605-01","article-title":"Neurodevelopmental outcomes comparing bevacizumab to laser for type 1 ROP.","volume":"50","author":"Rodriguez","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"eoi230064r28","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fpsyg.2018.01265","article-title":"Acceptability and reliability of the Bayley Scales of Infant and Toddler Development III among children in Bhaktapur, Nepal.","volume":"9","author":"Ranjitkar","year":"2018","journal-title":"Front Psychol"},{"key":"eoi230064r11","unstructured":"United States Census Bureau. Explore Census data. Accessed December 18, 2022. https:\/\/data.census.gov\/cedsci\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2810734\/jamaophthalmology_karmouta_2023_oi_230064_1702489051.53511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:02:21Z","timestamp":1703174541000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2810734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.4787","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}